A Novel Nanozyme to Enhance Radiotherapy Effects by Lactic Acid Scavenging, ROS Generation, and Hypoxia Mitigation
Advanced Science · 2024-07 · 11 (26)
DOI: 10.1002/advs.202403107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 05.05.2024. Verfasst von Yiran Yao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, 200011, P. R. China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Lactic Acid, Melanoma, Tumor Microenvironment. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Key Clinical Specialty, Shanghai Eye Disease Research Center, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Uveal melanoma (UM) is a leading intraocular malignancy with a high 5‐year mortality rate, and radiotherapy is the primary approach for UM treatment. However, the elevated lactic acid, deficiency in ROS, and hypoxic tumor microenvironment have severely reduced the radiotherapy outcomes. Hence, this study devised a novel CoMnFe‐layered double oxides (LDO) nanosheet with multienzyme activities for UM radiotherapy enhancement. On one hand, LDO nanozyme can catalyze hydrogen peroxide (H 2 O 2 ) in the tumor microenvironment into oxygen and reactive oxygen species (ROS), significantly boosting ROS production during radiotherapy. Simultaneously, LDO efficiently scavenged lactic acid, thereby impeding the DNA and protein repair in tumor cells to synergistically enhance the effect of radiotherapy. Moreover, density functional theory (DFT) calculations decoded the transformation pathway from lactic to pyruvic acid, elucidating a previously unexplored facet of nanozyme activity. The introduction of this innovative nanomaterial paves the way for a novel, targeted, and highly effective therapeutic approach, offering new avenues for the management of UM and other cancer types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, 200011, P. R. China.
- Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200011, P. R. China.
- State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai, 200050, P. R. China.
Förderung
- National Natural Science Foundation of China
- Shanghai Key Clinical Specialty, Shanghai Eye Disease Research Center
- China Postdoctoral Science Foundation
- Science and Technology Commission of Shanghai
- School of Medicine, Shanghai Jiao Tong University
- Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Zitieren
APA
Yao, Y., Xu, R., Shao, W., Tan, J., Wang, S., Chen, S., Zhuang, A., Liu, X., & Jia, R. (2024). A Novel Nanozyme to Enhance Radiotherapy Effects by Lactic Acid Scavenging, ROS Generation, and Hypoxia Mitigation. Advanced Science, 11(26). https://doi.org/10.1002/advs.202403107
Vancouver
Yao Y, Xu R, Shao W, Tan J, Wang S, Chen S, et al. A Novel Nanozyme to Enhance Radiotherapy Effects by Lactic Acid Scavenging, ROS Generation, and Hypoxia Mitigation. Advanced Science. 2024;11(26). doi:10.1002/advs.202403107
BibTeX
@article{Yao2024,
author = {Yao, Yiran and Xu, Ru and Shao, Weihuan and Tan, Ji and Wang, Shaoyun and Chen, Shuhan and Zhuang, Ai and Liu, Xuanyong and Jia, Renbing},
title = {A Novel Nanozyme to Enhance Radiotherapy Effects by Lactic Acid Scavenging, ROS Generation, and Hypoxia Mitigation},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {26},
doi = {10.1002/advs.202403107}
}
EUVIMED